Explore

Rapid Read Rapid Read
Shockwave Therapy: A Non-Surgical Option for Chronic Pain Relief

Shockwave Therapy: A Non-Surgical Option for Chronic Pain Relief

Shockwave therapy, also known as Extracorporeal Shockwave Therapy (ESWT), is gaining popularity as a non-invasive treatment for chronic musculoskeletal conditions. This therapy uses high-energy acoustic waves to stimulate the body's natural healing processes, improving blood circulation, reducing inflammation, and promoting tissue regeneration. Unlike surgical options, shockwave therapy requires no incisions or anesthesia, allowing patients to resume normal activities shortly after treatment. It is particularly effective for conditions like plantar fasciitis, tennis elbow, and Achilles tendon pain.
Trendline Trendline
Exercise Proven to Enhance Bone Health in Postmenopausal Women

Exercise Proven to Enhance Bone Health in Postmenopausal Women

Exercise Proven to Enhance Bone Health in Postmenopausal Women
Rapid Read Rapid Read
New Study Suggests Potential for Preserving Muscle Mass in Aging

New Study Suggests Potential for Preserving Muscle Mass in Aging

A recent study has identified a potential method for preserving muscle mass into old age by rejuvenating satellite cells, which are crucial for muscle regeneration. The research, conducted on mice, explored the use of compounds to protect proteins from chemical damage, thereby enhancing the activation of satellite cells. One compound, lipoic acid trisulfide (LASSS), showed promise in reducing protein nitration and improving muscle cell activation. While the study's findings are preliminary, they suggest that similar approaches could be explored for treating muscle wasting conditions in humans, such as those caused by chronic diseases.
Trendline Trendline
Limits of Extreme Biohacking: The Case for Basic Health Practices

Limits of Extreme Biohacking: The Case for Basic Health Practices

Limits of Extreme Biohacking: The Case for Basic Health Practices
Trendline Trendline
Aurenar Secures $5.7M to Advance Non-Invasive Neuromodulation for ICU Patients

Aurenar Secures $5.7M to Advance Non-Invasive Neuromodulation for ICU Patients

Aurenar Secures $5.7M to Advance Non-Invasive Neuromodulation for ICU Patients
Trendline Trendline
Experts Discuss the Role of Dance in Muscle Building and Fitness

Experts Discuss the Role of Dance in Muscle Building and Fitness

Experts Discuss the Role of Dance in Muscle Building and Fitness
Rapid Read Rapid Read
New Cancer Vaccine Platform Utilizes COVID-19 Immune Memory for Tumor Treatment

New Cancer Vaccine Platform Utilizes COVID-19 Immune Memory for Tumor Treatment

Researchers have developed a novel cancer vaccine platform, PROTEXI, which leverages pre-existing COVID-19 immune memory to enhance the body's ability to fight tumors. This dendritic cell vaccine uses the immune memory generated by SARS-CoV-2 infection or vaccination to stimulate a robust antitumor response. The platform pairs tumor-specific antigens with helper signals from the SARS-CoV-2 Spike protein, converting dormant antiviral memory into an active response against cancer cells. Preclinical studies have shown promising results, with the vaccine reducing tumor burden and improving survival rates in melanoma and breast cancer models.
Rapid Read Rapid Read
UNC Researchers Develop Light-Activated Cancer Treatment to Minimize Side Effects

UNC Researchers Develop Light-Activated Cancer Treatment to Minimize Side Effects

Researchers at the University of North Carolina at Chapel Hill are exploring a novel approach to cancer treatment that aims to reduce the chronic side effects often associated with traditional therapies. Led by Brianna Vickerman, a research assistant professor at the UNC Eshelman School of Pharmacy, the team is developing a method that uses light to activate cancer drugs only at the disease site. This technique involves encapsulating existing medications into carriers that circulate through the body without affecting healthy tissues. When the disease area is illuminated, the carriers release the drug precisely where needed. This approach builds on previous research involving light-controlled drug delivery for cardiovascular diseases. The project recently received a two-year commercialization-focused innovation grant to further test the technology in cancer models, with the ultimate goal of clinical development.
Trendline Trendline
Applied Biologics Extends Agreement with Providence Health Services for XWRAP Access

Applied Biologics Extends Agreement with Providence Health Services for XWRAP Access

Applied Biologics Extends Agreement with Providence Health Services for XWRAP Access
Trendline Trendline
Stretchable Antenna Enhances Wearable Health Sensors for Real-Time Monitoring

Stretchable Antenna Enhances Wearable Health Sensors for Real-Time Monitoring

Stretchable Antenna Enhances Wearable Health Sensors for Real-Time Monitoring
Trendline Trendline
Red Light Therapy Gains Popularity Among Americans for Wellness Benefits

Red Light Therapy Gains Popularity Among Americans for Wellness Benefits

Red Light Therapy Gains Popularity Among Americans for Wellness Benefits
Rapid Read Rapid Read
New Genetic Risk Factors for Fibromyalgia Identified in Major Study

New Genetic Risk Factors for Fibromyalgia Identified in Major Study

A recent study has identified new genetic risk factors for fibromyalgia, a chronic pain disorder, by examining the DNA of over two million individuals. The research, led by a global team including experts from King’s College London, found DNA sequence variants in 26 regions of the genome that affect the risk of developing fibromyalgia. The study suggests a genetic overlap between fibromyalgia and other conditions such as lower back pain and irritable bowel syndrome. The findings indicate that fibromyalgia represents a problem in pain processing, providing new insights into the biological pathways that could lead to new treatment approaches. The study also highlights the potential for existing pharmaceutical research, particularly in Huntington’s disease, to benefit fibromyalgia patients.